Medscape25d
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
CONTEXT: Decompensated congestive heart failure (CHF) is the leading hospital discharge diagnosis in patients older than 65 years. OBJECTIVE: To compare the efficacy and safety of intravenous ...
The New England Journal of Medicine1mon
Effects of Sublingual Administration of Nitroglycerin on Pulmonary-Artery Pressure in Patients with Failure of the Left Ventricle
CHEST discomfort associated with paroxysmal nocturnal dyspnea is frequently quite distressing, and some patients describe this discomfort as pain. 1 During the past several years, we have noted in ...
Medscape1mon
Clinical and Hemodynamic Effects of Nesiritide (B-Type Natriuretic Peptide) in Patients With Decompensated Heart Failure Receiving Beta-Blockers
In the VMAC trial, 33% of all the patients were treated chronically with β blockers and 25% (123/489) had received a β blocker within 24 hours before the start of study drug. Among patients who ...